Although patients without neoplasia were selected, aberrant methylation of the CCNA1, DAPK, DCC and MGMT genes was present in the pretreatment oral rinse samples in all participants of both groups, an epigenetic event that is the target of action of valproic acid. The gene discussed is DAPK1; the disease is neoplasm.